BioLife Sciences Inc.
BLFE · OTC
11/30/2020 | 11/30/2019 | 11/30/2018 | 11/30/2017 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $35 | $0 | $1 | $12 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $37 | $0 | $0 | $0 |
| Total Curr. Assets | $72 | $0 | $1 | $12 |
| Property Plant & Equip (Net) | $1 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $73 | $0 | $1 | $12 |
| Liabilities | – | – | – | – |
| Payables | $493 | $0 | $80 | $0 |
| Short-Term Debt | $190 | $0 | $76 | $74 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $80 | $1 | $0 | $55 |
| Total Curr. Liab. | $762 | $1 | $156 | $129 |
| LT Debt | $0 | $0 | $67 | $67 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $67 | $67 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $762 | $1 | $222 | $195 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $5 | $0 | $349 | $334 |
| Retained Earnings | -$1,269 | -$1 | -$4,895 | -$4,842 |
| AOCI | -$36 | $0 | $0 | -$334 |
| Other Equity | $610 | $0 | $4,325 | $4,659 |
| Total Equity | -$690 | -$1 | -$221 | -$183 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $73 | $0 | $1 | $12 |
| Net Debt | $155 | -$0 | $141 | $128 |